NDC 76381-314

ISOVUE 200

Iopamidol

ISOVUE 200 is a Intravascular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bipso Gmbh. The primary component is Iopamidol.

Product ID76381-314_5c4ac062-d59d-f667-f218-1572e3d8cde8
NDC76381-314
Product TypeHuman Prescription Drug
Proprietary NameISOVUE 200
Generic NameIopamidol
Dosage FormInjection, Solution
Route of AdministrationINTRAVASCULAR
Marketing Start Date1985-12-31
Marketing CategoryNDA / NDA
Application NumberNDA018735
Labeler NameBIPSO GmbH
Substance NameIOPAMIDOL
Active Ingredient Strength408 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 76381-314-30

10 VIAL, SINGLE-DOSE in 1 BOX (76381-314-30) > 50 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date1985-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
IOPAMIDOL408 mg/mL

OpenFDA Data

SPL SET ID:764f5085-7ee8-fdba-2c5b-ae6721014a94
Manufacturer
UNII

Pharmacological Class

  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]

NDC Crossover Matching brand name "ISOVUE 200" or generic name "Iopamidol"

NDCBrand NameGeneric Name
76381-314ISOVUE 200ISOVUE 200
0270-1314ISOVUEIOPAMIDOL
0270-1315ISOVUEIOPAMIDOL
0270-1316ISOVUEIOPAMIDOL
0270-1317ISOVUEIOPAMIDOL

Trademark Results [ISOVUE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ISOVUE
ISOVUE
85423219 4243227 Dead/Cancelled
Centrix, Inc.
2011-09-15
ISOVUE
ISOVUE
75239760 2132582 Dead/Cancelled
BRACCO DIAGNOSTICS, INC.
1997-02-07
ISOVUE
ISOVUE
73299442 1237972 Live/Registered
E. R. Squibb & Sons, Inc.
1981-02-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.